Cargando…
Delivery of Intraocular Triamcinolone Acetonide in the Treatment of Macular Edema
Macular edema (ME) is one of the eventual outcomes of various intraocular and systemic pathologies. The pathogenesis for ME is not yet entirely understood; however, some of the common risk factors for its development have been identified. While this investigation will not discuss the numerous etiolo...
Autores principales: | Pickrell, Aaron, Harris, Alon, Ngo, Sandra, Amireskandari, Annahita, Stewart, Erin, Siesky, Brent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834899/ https://www.ncbi.nlm.nih.gov/pubmed/24300190 http://dx.doi.org/10.3390/pharmaceutics4010230 |
Ejemplares similares
-
Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular Edema
por: Zakaria, Yousra Gamal, et al.
Publicado: (2022) -
Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema
por: Fung, Simon, et al.
Publicado: (2022) -
Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema
por: Cellini, Mauro, et al.
Publicado: (2008) -
Dose Dependent Effects of Intravitreal Triamcinolone Acetonide on Diffuse Diabetic Macular Edema
por: Bae, Joon Sung, et al.
Publicado: (2009) -
Intravitreal versus Posterior Subtenon Injection of Triamcinolone Acetonide for Diabetic Macular Edema
por: Choi, Young Jae, et al.
Publicado: (2006)